Baheal Pharma Group is a healthcare industry group driven by technological innovation, with core businesses spanning medical innovation incubation, manufacturing, and commercialization. Leveraging deep insights into clinical needs and advanced incubation mechanisms, Baheal has established a Research and Development Platform through collaborating with leading national research institutions to discover original innovations based on basic biological R&D and innovative achievements investment incubation with First-in-Class potential. Baheal Pharma Group's listed subsidiary, Baheal Medical, as an industrialization platform with innovation brand-building capabilities, aims to accelerate the translation of medical innovations into clinical practice and improve patient outcomes. Today, Baheal has built a diversified portfolio across bone health, organ fibrosis, and brain metastases, and has successfully incubated multiple category-leading brands.